PR Newswire Clinical TrialsOriginal article
Dr. Philip S. Low Inducted into 2026 ACS Division of Medicinal Chemistry Hall of Fame
Three FDA-approved medicinesPositive
AI Analysis
Summary
Dr. Philip S. Low, founder of the Low Institute for Therapeutics at Purdue University, was posthumously inducted into the 2026 ACS Division of Medicinal Chemistry Hall of Fame in recognition of his targeted-therapy research that resulted in three FDA-approved medicines.
Importance:2/10
Sentiment:
0.80
honors and awardsdrug discoverytargeted therapyFDA approvalsposthumous recognition
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 31, 2026 11:00 AM